Arine operates an AI-powered medication intelligence platform designed to address one of healthcare's more costly and underappreciated problems: medication mismanagement. In the United States, the issue accounts for an estimated $528 billion in annual costs and roughly 275,000 deaths per year. Arine's platform applies machine learning, data science, and clinical expertise to identify patients at risk of medication-related harm before adverse events occur, generating recommendations to improve safety, effectiveness, and appropriateness of treatment at scale.
The platform integrates clinical, behavioral, and social determinants of health data to build a fuller picture of each patient. It currently serves more than 45 health plans covering over 30 million members, producing upwards of 40 million recommendations annually. Reported outcomes include reductions in hospitalizations of up to 40%, a 10–15% decrease in total cost of care, and support for clients in achieving 4–5 star quality ratings.
Arine's work sits at the intersection of population health management and clinical decision support, with health plans and payers as its primary customers. The engineering and data science challenges involved span predictive analytics, large-scale data integration, and the operationalization of clinical intelligence across diverse patient populations.
